Our Recommendations
- WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever (2025)
- Laboratory testing for dengue virus: interim guidance, April 2025 (2025)
- Laboratory testing for Zika virus and dengue virus infections: interim guidance (2022)
- Handbook For Clinical Management Of Dengue (2012)
- Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika (2023)
New Publications
- Laboratory testing for dengue virus: interim guidance, April 2025 (2025)
- WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever (2025)
- Chikungunya: Clinical Management in dengue-endemic areas (2014)
- Guia nacional para el maejo de la enfermedad por el virus de la chikungunya (2015)
- An evaluation of global Chikungunya clinical management guidelines: A systematic review (2022)
Filter
52
Featured
Recommendations
5
New Publications
2
Language
Document type
Guidelines
25
Resource Platforms
13
Fact sheets
5
Studies & Reports
3
Manuals
2
Online Courses
2
Training Material
1
Situation Updates
1
Countries / Regions
Global
17
Latin America and the Carribbean
1
South–East Asia Region
1
Bangladesh
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
12
Pharmacy & Technologies
2
Capacity Building
1
Public Health
1
Countries
1
WHO guidelines for clinical management of arboviral diseases: dengue, chikungunya, Zika and yellow fever
recommended
The new WHO guidelines provide clinical management recommendations for four of the most widespread arboviruses affecting humans: dengue, chikungunya, Zika, and yellow fever.
An integrated approach is vital, as these four diseases often present with similar symptoms, especially in the early stages...
This guidance synthesizes current evidence on dengue laboratory testing and diagnostics and provides practical recommendations for laboratories, clinicians, public health officials, and programme managers involved in dengue diagnosis, surveillance, and control, in the context of the global emergency...
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by...
Website last accessed on 31.03.2023
Dengue vaccine for 9 to 16 year old's with previous dengue infection.
Website last accessed on 10.04.2023
Websites last accessed on 31.03.2023
Dengue testing guidance according to days of symptom onset.
Website last accessed on 31.03.2023
Learn about dengue virus infection symptoms and treatment.
Case definitions, clinical classification, and disease phases Dengue, Chikungunya, and Zika
recommended
A person who lives in or has traveled in the previous 14 days to areas with dengue transmission, and presents with acute fever that has typically lasted 2 to 7 days, and two or more of the following clinical manifestations: nausea or vomiting, exanthema, headache or retro-orbital pain, myalgia or ar...
Website last accessed on 31.03.2023
Learn about dengue clinical presentation and classification.
Website last accessed on 31.03.2023
Conozca la presentación clínica y la clasificación del dengue.
Website last accessed on 31.03.2023
Learn about dengue diagnosis and testing guidance.
Version corregida. En la actualidad, las guías basadas en la evidencia constituyen una de las herramientas más útiles para mejorar la salud pública y la práctica clínica. Su finalidad es formular intervenciones con sólidas pruebas de eficacia, evitar riesgos innecesarios, utilizar los recurso...
Biosensors and Bioelectronics: X Volume 10, May 2022, 100100; This article provides an overview of dengue disease, the working principles, the significance of the various conventional and biosensor detection strategies, the benefits and problematic conditions of the reported methods. The present hu...
En la actualidad, las guías basadas en la evidencia constituyen una de las herramientas más útiles para mejorar la salud pública y la práctica clínica. Su finalidad es formular intervenciones con sólidas pruebas de eficacia, evitar riesgos innecesarios, utilizar los recursos de forma eficient...
Zika and dengue viruses remain significant public health threats. These viruses share the same Aedes (Stegomyia) mosquito vectors and geographic distributions but infections cannot be readily distinguished clinically and need to be differentiated from each other, and from other circulating arboviral...
Evidence-based guidelines are one of the most useful tools for improving public health and clinical practice. Their purpose is to formulate interventions based on strong evidence of efficacy, avoid unnecessary risks, use resources efficiently, reduce clinical variability and, in essence, improve hea...
Chikungunya virus (CHIKV) has expanded its geographical reach in recent decades and is an emerging global health threat. CHIKV can cause significant morbidity and lead to chronic, debilitating arthritis/arthralgia in up to 40% of infected individuals. Prevention, early identification, and clinical m...
aprender sobre la presentación clínica y la clasificación
Learn about dengue clinical presentation and classification.
